Alopecia Areata
November 2025
in “
Nature Reviews Disease Primers
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study 127
- Quality of Life, Psychosocial Difficulties and Bullying in Pediatric Patients with Alopecia Areata: A European Cross-Sectional Study
- Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients
- Perceived Stigma Among Adults With Alopecia Areata In The United States
- Psychosocial Burden and the Impact of Illness Perceptions and Stigma on Quality of Life, Anxiety, and Depression in Alopecia Areata: Results from the Alopecia + Me Study
- Psychosocial and Occupational Burden on Caregivers of Adolescents With Alopecia Areata in Australia
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents With Alopecia Areata
- Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus 0.1% Ointment in Patients with Localized Alopecia Areata: A Triple-Arm Randomized Clinical Study
- Patient-Reported Outcome Improvements Following Scalp Hair Regrowth Among Patients With Alopecia Areata: Analysis of the ALLEGRO-2b/3 Trial
- The Role of Minoxidil in the Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata
- Alopecia Areata Exhibits Cutaneous And Systemic OX40 Activation Across Atopic Backgrounds
- Lifetime Incidence and Healthcare Disparities in Alopecia Areata: A UK Population-Based Cohort Study
- Dupilumab Induces Hair Regrowth in Pediatric Alopecia Areata: A Real-World, Single-Center Observational Study
- Efficacy and Safety of Deuruxolitinib, an Oral Selective Janus Kinase Inhibitor, in Adults with Alopecia Areata: Results from the Phase 3 Randomized, Controlled Trial (THRIVE-AA1)
- Dupilumab for the Treatment of Alopecia Areata in Pediatric Patients with Atopic Dermatitis: A Scoping Review
- Association Between Natural Hair Color, Race, And Alopecia
- Retracted: Genetic Association Between Asthma and Alopecia Areata: A Two-Sample Mendelian Randomization Study
- Psychosocial and Mental Impact of Alopecia Areata: Analysis of the Danish Skin Cohort
- Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib
- Epidemiology, Treatment Patterns, And Healthcare Resource Utilization Study Of Patients With Alopecia Areata In Taiwan's National Health Insurance Research Database
- Health-Related Quality of Life of Adult and Adolescent Patients Living with Alopecia Areata in Australia
- Evaluation of Quality of Life Scores and Family Impact Scales in Pediatric Patients with Alopecia Areata: A Cross-Sectional Cohort Study
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Long-Term Efficacy and Safety of Baricitinib in Patients With Severe Alopecia Areata: 104-Week Results From BRAVE-AA1 and BRAVE-AA2
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Mendelian Randomization Study Highlights Hypothyroidism as a Causal Determinant of Alopecia Areata
- European Expert Consensus Statement on the Systemic Treatment of Alopecia Areata
- Alopecia Areata and Season of Onset: A Retrospective Study of 492 Cases
- A Clinical Investigation of Early-Onset Alopecia Areata in Children: Onset Earlier Than 4 Years of Age Might Have a Better Short-Term Prognosis
- Comorbid Conditions Associated With Alopecia Areata: A Systematic Review and Meta-Analysis
- Alopecia Areata Clinical Trial Enrollment and Retention Outcome Factors Among Underrepresented Ethnic and Racial Groups: A Cross-Sectional Study
- Incidence and Prevalence of Alopecia Areata in the Australian Primary Care Setting: A Retrospective Analysis of Electronic Health Record Data
- Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- The Invisible Impact Of A Visible Disease: Psychosocial Impact Of Alopecia Areata
- Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
- Involvement of ILC1-Like Innate Lymphocytes in Human Autoimmunity: Lessons from Alopecia Areata
- Alopecia Areata in Underrepresented Groups: Preliminary Analysis of the All of Us Research Program
- Integrative and Mechanistic Approach to the Hair Growth Cycle and Hair Loss
- Quality of Life in Children and Adolescents With Alopecia Areata: A Systematic Review
- Nonscarring Alopecias
- Alopecia Areata and Risk of Atopic and Autoimmune Conditions: Population-Based Cohort Study
- Beyond The Hot Comb: Updates In Epidemiology, Pathogenesis, And Treatment Of Central Centrifugal Cicatricial Alopecia From 2011 To 2021
- Prevalence, Comorbidities, and Treatment Patterns of Japanese Patients with Alopecia Areata: A Descriptive Study Using Japan Medical Data Center Claims Database
- Scalp Biomarkers During Dupilumab Treatment Support Th2 Pathway Pathogenicity in Alopecia Areata
- Efficacy and Safety of Baricitinib in Adult Patients With Severe Alopecia Areata With or Without an Atopic Background From Two Randomized, Placebo-Controlled, Phase 3 Trials
- Analysis of Alopecia Areata Surveys Suggests a Threshold for Improved Patient-Reported Outcomes
- Epidemiological, Clinical, and Trichoscopic Features of Syphilitic Alopecia: A Retrospective Analysis and Systematic Review
- Lifestyle Factors Involved in the Pathogenesis of Alopecia Areata
- Ritlecitinib And Brepocitinib Demonstrate Significant Improvement In Scalp Alopecia Areata Biomarkers
- The Epidemiology of Alopecia Areata: A Population-Based Cohort Study in UK Primary Care
- Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
- Telogen Effluvium: A Review of the Science and Current Obstacles
- Common Causes of Hair Loss: Clinical Manifestations, Trichoscopy, and Therapy
- Utility of Azathioprine, Methotrexate, and Cyclosporine as Steroid-Sparing Agents in Chronic Alopecia Areata: A Retrospective Study of Continuation Rates in 138 Patients
- Hair Follicle Immune Privilege and Its Collapse in Alopecia Areata
- Efficacy of Antihistamines in Combination with Topical Corticosteroid and Superficial Cryotherapy for Treatment of Alopecia Areata: A Retrospective Cohort Study
- The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials
- Female Androgenetic Alopecia: An Update on Diagnosis and Management
- Topical Calcipotriol vs Narrowband Ultraviolet B in Treatment of Alopecia Areata: A Randomized-Controlled Trial
- All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata
- Treatment of Alopecia Areata: An Australian Expert Consensus Statement
- Recalcitrant Alopecia Areata Responsive to Leflunomide and Anthralin—Potentially Undiscovered JAK/STAT Inhibitors?
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Comorbidities in Alopecia Areata: A Systematic Review and Meta-Analysis
- An Integrated Model of Alopecia Areata Biomarkers Highlights Both TH1 and TH2 Upregulation
- Topical 2% Tofacitinib for Children with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Nail Changes in Alopecia Areata: An Update and Review
- Race and Alopecia Areata Amongst US Women
- Objective Outcome Measures: Collecting Meaningful Data on Alopecia Areata
- Tofacitinib 2% Ointment, a Topical Janus Kinase Inhibitor, for the Treatment of Alopecia Areata: A Pilot Study of 10 Patients
- Topical Janus Kinase Inhibitors for the Treatment of Pediatric Alopecia Areata
- Androgenetic Alopecia: A Review
- Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata
- Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata
- Diagnosis and Management of Hair Loss in Children
- All Hairstyles Are Not Created Equal: What the Dermatologist Needs to Know About Black Hairstyling Practices and the Risk of Traction Alopecia
- Pulse Corticosteroid Therapy With Oral Dexamethasone for the Treatment of Adult Alopecia Totalis and Universalis
- Vasoactive Intestinal Peptide, Whose Receptor-Mediated Signaling May Be Defective in Alopecia Areata, Provides Protection from Hair Follicle Immune Privilege Collapse
- A Comparative Study of Oral Cyclosporine and Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Quality of Life in Patients with Alopecia Areata: A Hospital-Based Cross-Sectional Study
- Retrospective Review of Diphencyprone in the Treatment of Alopecia Areata
- Alopecia: Children Are Not Just Little People
- The Role of Lymphocytes in the Development and Treatment of Alopecia Areata
- Alopecia Areata Profiling Shows TH1, TH2, and IL-23 Cytokine Activation Without Parallel TH17/TH22 Skewing
- Congenital Triangular Alopecia: Is It Always Confined to the Fronto-Temporal Region?
- Plasmacytoid Dendritic Cells in Alopecia Areata: Missing Link?
- Clinical Observations in Alopecia Areata: Implications and Hypotheses
- Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- The Effect of Oral Cyclosporine in the Treatment of Severe Alopecia Areata
- Pulse Corticosteroid Therapy for Alopecia Areata in Children: A Retrospective Study
- Autoimmune Disease Induction in a Healthy Human Organ: A Humanized Mouse Model of Alopecia Areata
- Alopecia Areata Update
- Calcitonin Gene-Related Peptide (CGRP) May Award Relative Protection from Interferon-γ-Induced Collapse of Human Hair Follicle Immune Privilege
- Central Centrifugal Cicatricial Alopecia: An Approach to Diagnosis and Management
- Narrowband Ultraviolet B Phototherapy for Alopecia Areata
- Clinical Severity Does Not Reliably Predict Quality of Life in Women With Alopecia Areata, Telogen Effluvium, or Androgenic Alopecia
- Efficacy and Tolerability of Methotrexate in Severe Childhood Alopecia Areata
- Trichohyalin Is a Potential Major Autoantigen in Human Alopecia Areata
- Bilateral Treatment for Alopecia Areata
- Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity
- Experimental Evaluation of Ebastine, a Second-Generation Antihistamine, as a Supportive Medication for Alopecia Areata
- Type 1 Interferon Signature in the Scalp Lesions of Alopecia Areata
- Alopecia Areata Update
- Alopecia Areata Update
- The Hair Follicle as a Dynamic Mini-Organ
- Acute Diffuse And Total Alopecia: A New Subtype Of Alopecia Areata With A Favorable Prognosis
- The C3H/HeJ Mouse and DEBR Rat Models for Alopecia Areata: Review of Preclinical Drug Screening Approaches and Results
- Maintenance of Hair Follicle Immune Privilege Is Linked to Prevention of NK Cell Attack
- Probing the Effects of Stress Mediators on the Human Hair Follicle
- Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial
- Placebo-Controlled Oral Pulse Prednisolone Therapy in Alopecia Areata
- Clobetasol Propionate 0.05% Under Occlusion in the Treatment of Alopecia Totalis/Universalis
- Role of the Autoimmune Regulator (AIRE) Gene in Alopecia Areata: Strong Association of a Potentially Functional AIRE Polymorphism With Alopecia Universalis
- Acute Diffuse and Total Alopecia of the Female Scalp
- Twice Weekly 5 mg Dexamethasone Oral Pulse in the Treatment of Extensive Alopecia Areata
- The Biology of Hair Follicles
- Experimental Induction of Alopecia Areata-Like Hair Loss in C3H/HeJ Mice Using Full-Thickness Skin Grafts
- Alopecia Areata in Aging C3H/HeJ Mice
- Failure of Passive Transfer of Serum From Patients With Alopecia Areata and Alopecia Universalis to Inhibit Hair Growth in Transplants of Human Scalp Skin Grafted Onto Nude Mice
- Hair Anatomy for the Clinician
- Juvenile Versus Maturity-Onset Alopecia Areata: A Comparative Retrospective Clinical Study
- Topical Minoxidil Solution (1% and 5%) in the Treatment of Alopecia Areata